Brief: Harvard Apparatus Regenerative Technology updates patient status
17/10/2014 13:30
Oct 17 (Reuters) - Harvard Apparatus Regenerative Technology Inc HART.O : * Updates patient status * Says has not been informed of the cause of death * Been informed by the principal investigator that one of the patients in that study has recently passed away * Patient survived more than two years from the initial regenerated trachea transplant surgery that took place in 2012 * Source text for Eikon ID:nBw9Xc6LNa * Further company coverage HART.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer